GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Akso Health Group (NAS:AHG) » Definitions » EV-to-EBITDA

Akso Health Group (Akso Health Group) EV-to-EBITDA : -6.67 (As of May. 11, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Akso Health Group EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Akso Health Group's enterprise value is $101.15 Mil. Akso Health Group's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was $-15.16 Mil. Therefore, Akso Health Group's EV-to-EBITDA for today is -6.67.

The historical rank and industry rank for Akso Health Group's EV-to-EBITDA or its related term are showing as below:

AHG' s EV-to-EBITDA Range Over the Past 10 Years
Min: -22.86   Med: -0.81   Max: 63.93
Current: -6.67

During the past 9 years, the highest EV-to-EBITDA of Akso Health Group was 63.93. The lowest was -22.86. And the median was -0.81.

AHG's EV-to-EBITDA is ranked worse than
100% of 80 companies
in the Medical Distribution industry
Industry Median: 10.495 vs AHG: -6.67

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-11), Akso Health Group's stock price is $0.68. Akso Health Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.240. Therefore, Akso Health Group's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Akso Health Group EV-to-EBITDA Historical Data

The historical data trend for Akso Health Group's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akso Health Group EV-to-EBITDA Chart

Akso Health Group Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only -18.70 -0.78 -11.00 -6.31 -0.02

Akso Health Group Semi-Annual Data
Mar15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -6.31 - -0.02 -

Competitive Comparison of Akso Health Group's EV-to-EBITDA

For the Medical Distribution subindustry, Akso Health Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Akso Health Group's EV-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Akso Health Group's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Akso Health Group's EV-to-EBITDA falls into.



Akso Health Group EV-to-EBITDA Calculation

Akso Health Group's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=101.151/-15.162
=-6.67

Akso Health Group's current Enterprise Value is $101.15 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Akso Health Group's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was $-15.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Akso Health Group  (NAS:AHG) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Akso Health Group's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.68/-0.240
=At Loss

Akso Health Group's share price for today is $0.68.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Akso Health Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.240.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Akso Health Group EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Akso Health Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Akso Health Group (Akso Health Group) Business Description

Traded in Other Exchanges
Address
No. 44, Moscow Road, Qianwan Bonded Port Area, Room 8201-4-4(A), 2nd Floor, Qiantongyuan Building, Qingdao Pilot Free Trade Zone, Shandong, CHN
Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It operates in two segments namely online marketplace and health devices. It generates the majority of revenue from the health devices segment.